Amedeo Smart

Free Medical Literature Service



Alzheimer's Disease

  Free Subscription

Articles published in
Exp Gerontol
    October 2022
  1. SAYEHMIRI F, Khodagholi F, Pourbadie HG, Naderi N, et al
    Phosphonate analog of 2-oxoglutarate regulates glutamate-glutamine homeostasis and counteracts amyloid beta induced learning and memory deficits in rats.
    Exp Gerontol. 2022;168:111944.
    >> Share

    September 2022
  2. ABUELEZZ NZ, Nasr FE, Abdel Aal WM, Molokhia T, et al
    Sera miR-34a, miR-29b and miR-181c as potential novel diagnostic biomarker panel for Alzheimers in the Egyptian population.
    Exp Gerontol. 2022;169:111961.
    >> Share

  3. HE X, Yan C, Zhao S, Zhao Y, et al
    The preventive effects of probiotic Akkermansia muciniphila on D-galactose/AlCl3 mediated Alzheimer's disease-like rats.
    Exp Gerontol. 2022 Sep 21:111959. doi: 10.1016/j.exger.2022.111959.
    >> Share

  4. COUTINHO LA, Leao LL, Cassilhas RC, de Paula AMB, et al
    Alzheimer's disease genes and proteins associated with resistance and aerobic training: An in silico analysis.
    Exp Gerontol. 2022 Sep 7:111948. doi: 10.1016/j.exger.2022.111948.
    >> Share

  5. NABIZADEH F, Kankam SB, Balabandian M, Hashemi SM, et al
    Metformin use and brain atrophy in nondemented elderly individuals with diabetes.
    Exp Gerontol. 2022;166:111890.
    >> Share

  6. KAMENO K, Hasegawa Y, Hayashi K, Takemoto Y, et al
    Loss of body weight in old 5xFAD mice and the alteration of gut microbiota composition.
    Exp Gerontol. 2022;166:111885.
    >> Share

    August 2022
  7. PLACIDO J, de Almeida CAB, Ferreira JV, de Oliveira Silva F, et al
    Spatial navigation in older adults with mild cognitive impairment and dementia: A systematic review and meta-analysis.
    Exp Gerontol. 2022;165:111852.
    >> Share

  8. GARCIA-VELAZQUEZ L, Lopez-Carrasco P, Arias C
    Age-dependent changes in Wnt signaling components and synapse number are differentially affected between brain regions.
    Exp Gerontol. 2022;165:111854.
    >> Share

  9. KURAPOVA R, Chouliaras L, O'Brien JT
    The promise of amplification assays for accurate early detection of alpha-synucleinopathies: A review.
    Exp Gerontol. 2022;165:111842.
    >> Share

    July 2022
  10. AKUSHEVICH I, Yashkin AP, Kravchenko J, Kertai MD, et al
    Extended anesthesia exposure for abdominal and pelvic procedures in older adults with colorectal cancer: Associations with chart dementia diagnoses.
    Exp Gerontol. 2022;164:111830.
    >> Share

    May 2022
  11. REISS AB, Ahmed S, Dayaramani C, Glass AD, et al
    The role of mitochondrial dysfunction in Alzheimer's disease: A potential pathway to treatment.
    Exp Gerontol. 2022 May 1:111828. doi: 10.1016/j.exger.2022.111828.
    >> Share

    April 2022
  12. BAZRGAR M, Khodabakhsh P, Dargahi L, Mohagheghi F, et al
    MicroRNA modulation is a potential molecular mechanism for neuroprotective effects of intranasal insulin administration in amyloid betaeta oligomer induced Alzheimer's like rat model.
    Exp Gerontol. 2022;164:111812.
    >> Share

    January 2022
  13. GLASMAN P, Houot M, Migliaccio R, Bombois S, et al
    Subtle postoperative cognitive disorder in preclinical Alzheimer's disease.
    Exp Gerontol. 2022 Jan 29:111715. doi: 10.1016/j.exger.2022.111715.
    >> Share

  14. TARBALI S, Zahmatkesh M, Torkaman-Boutorabi A, Khodagholi F, et al
    Assessment of lipophilic fluorescence products in beta-amyloid-induced cognitive decline: A parallel track in hippocampus, CSF, plasma and erythrocytes.
    Exp Gerontol. 2022;157:111645.
    >> Share

    August 2021
  15. LI P, Wu Q, Li X, Hu B, et al
    Shenqi Yizhi Granule attenuates Abeta1-42 induced cognitive dysfunction via inhibiting JAK2/STAT3 activated astrocyte reactivity.
    Exp Gerontol. 2021;151:111400.
    >> Share

    July 2021
  16. VASCONCELOS-FILHO FSL, da Rocha Oliveira LC, de Freitas TBC, de Pontes PADS, et al
    Effect of involuntary chronic physical exercise on beta-amyloid protein in experimental models of Alzheimer's disease: Systematic review and meta-analysis.
    Exp Gerontol. 2021 Jul 30:111502. doi: 10.1016/j.exger.2021.111502.
    >> Share

  17. VATANABE IP, Pedroso RV, Manzine PR, Chagas MHN, et al
    ADAM10: Biomarker of mild cognitive impairment but not of cognitive frailty.
    Exp Gerontol. 2021;149:111303.
    >> Share

    June 2021
  18. GALLO A, Pillet LE, Verpillot R
    New frontiers in Alzheimer's disease diagnostic: Monoamines and their derivatives in biological fluids.
    Exp Gerontol. 2021;152:111452.
    >> Share

    May 2021
  19. CEZAR NOC, Aprahamian I, Ansai JH, de Oliveira MPB, et al
    Feasibility of reducing frailty components in older adults with Alzheimer's dementia: a randomized controlled home-based exercise trial (AD-HOMEX).
    Exp Gerontol. 2021;150:111390.
    >> Share

  20. LIU L, Cao J, Huang C, Yuan E, et al
    Analysis the alteration of systemic inflammation in old and young APP/PS1 mouse.
    Exp Gerontol. 2021;147:111274.
    >> Share

  21. YANG I, Arthur RA, Zhao L, Clark J, et al
    The oral microbiome and inflammation in mild cognitive impairment.
    Exp Gerontol. 2021;147:111273.
    >> Share

    April 2021
  22. TZEKAKI EE, Tsolaki M, Pantazaki AlphaA, Geromichalos G, et al
    The pleiotropic beneficial intervention of olive oil intake on the Alzheimer's disease onset via fibrinolytic system.
    Exp Gerontol. 2021 Apr 6:111344. doi: 10.1016/j.exger.2021.111344.
    >> Share

    March 2021
  23. XIAO QY, Ye TY, Wang XL, Han L, et al
    A network pharmacology-based study on key pharmacological pathways and targets of Qi Fu Yin acting on Alzheimer's disease.
    Exp Gerontol. 2021 Mar 27:111336. doi: 10.1016/j.exger.2021.111336.
    >> Share

  24. PINI L, Wennberg AM
    Structural imaging outcomes in subjective cognitive decline: Community vs. clinical-based samples.
    Exp Gerontol. 2021;145:111216.
    >> Share

    February 2021
  25. EGASHIRA R, Umezaki Y, Mizutani S, Obata T, et al
    Relationship between cerebral atrophy and number of present teeth in elderly individuals with cognitive decline.
    Exp Gerontol. 2021;144:111189.
    >> Share

    January 2021
  26. FERNANDEZ FX, Kaladchibachi S, Negelspach DC
    Resilience in the suprachiasmatic nucleus: Implications for aging and Alzheimer's disease.
    Exp Gerontol. 2021;147:111258.
    >> Share

  27. BLASKO I, Defrancesco M, Oberacher H, Loacker L, et al
    Plasma phosphatidylcholines and vitamin B12/folate levels are possible prognostic biomarkers for progression of Alzheimer's disease.
    Exp Gerontol. 2021 Jan 28:111264. doi: 10.1016/j.exger.2021.111264.
    >> Share

  28. YAN T, Liu B, Wang N, Liao Z, et al
    The flavonoids of okra insulates against oxidative stress, neuroinflammation and restores BDNF levels in Abeta1-42 induced mouse model of Alzheimer's disease.
    Exp Gerontol. 2021;147:111263.
    >> Share

  29. SOYSAL P, Tan SG, Smith L
    A comparison of the prevalence of Fear of Falling between older patients with Lewy body dementia, Alzheimer's disease, and without dementia.
    Exp Gerontol. 2021;146:111248.
    >> Share

  30. AL-HARRASI AM, Iqbal E, Tsamakis K, Lasek J, et al
    Motor signs in Alzheimer's disease and vascular dementia: Detection through natural language processing, co-morbid features and relationship to adverse outcomes.
    Exp Gerontol. 2021 Jan 12:111223. doi: 10.1016/j.exger.2020.111223.
    >> Share

    December 2020
  31. TZEKAKI EE, Papaspyropoulos A, Tsolaki M, Lazarou E, et al
    Restoration of BMI1 levels after the administration of early harvest extra virgin olive oil as a therapeutic strategy against Alzheimer's disease.
    Exp Gerontol. 2020 Dec 5:111178. doi: 10.1016/j.exger.2020.111178.
    >> Share

  32. LIU Q, Lei C
    Neuroprotective effects of miR-331-3p through improved cell viability and inflammatory marker expression: Correlation of serum miR-331-3p levels with diagnosis and severity of Alzheimer's disease.
    Exp Gerontol. 2020;144:111187.
    >> Share

  33. ZHANG J, Wang R
    Deregulated lncRNA MAGI2-AS3 in Alzheimer's disease attenuates amyloid-beta induced neurotoxicity and neuroinflammation by sponging miR-374b-5p.
    Exp Gerontol. 2020;144:111180.
    >> Share

  34. SCHIMIDT HL, Carrazoni GS, Garcia A, Izquierdo I, et al
    Strength training or green tea prevent memory deficits in a beta-amyloid peptide-mediated Alzheimer's disease model.
    Exp Gerontol. 2020;143:111186.
    >> Share

    September 2020
  35. YADAV J, Verma AK, Garg RK, Ahmad K, et al
    Sialic acid associated with oxidative stress and total antioxidant capacity (TAC) expression level as a predictive indicator in moderate to severe Alzheimer's disease.
    Exp Gerontol. 2020 Sep 26:111092. doi: 10.1016/j.exger.2020.111092.
    >> Share

    August 2020
  36. WANG R, Zhang J
    Clinical significance of miR-433 in the diagnosis of Alzheimer's disease and its effect on Abeta-induced neurotoxicity by regulating JAK2.
    Exp Gerontol. 2020 Aug 29:111080. doi: 10.1016/j.exger.2020.111080.
    >> Share

    June 2020
  37. FERNANDES A, Tabuas-Pereira M, Duro D, Lima M, et al
    C-reactive protein as a predictor of mild cognitive impairment conversion into Alzheimer's disease dementia.
    Exp Gerontol. 2020 Jun 16:111004. doi: 10.1016/j.exger.2020.111004.
    >> Share

    April 2020
  38. KIM YJ, Kim SH, Park Y, Park J, et al
    miR-16-5p is upregulated by amyloid beta deposition in Alzheimer's disease models and induces neuronal cell apoptosis through direct targeting and suppression of BCL-2.
    Exp Gerontol. 2020 Apr 19:110954. doi: 10.1016/j.exger.2020.110954.
    >> Share

  39. MUNDO IG, Vielma NMP, Lopez MG, Fleury A, et al
    DNA methylation of the RE-1 silencing transcription factor in peripheral blood mononuclear cells and gene expression of antioxidant enzyme in patients with late-onset Alzheimer disease.
    Exp Gerontol. 2020 Apr 16:110951. doi: 10.1016/j.exger.2020.110951.
    >> Share

  40. SCARABINO D, Peconi M, Broggio E, Gambina G, et al
    Relationship between proinflammatory cytokines (Il-1beta, Il-18) and leukocyte telomere length in mild cognitive impairment and Alzheimer's disease.
    Exp Gerontol. 2020;136:110945.
    >> Share

  41. DE OLIVEIRA SILVA F, Ferreira JV, Placido J, Chagas D, et al
    Corrigendum to "Gait analysis with videogrammetry can differentiate healthy elderly, mild cognitive impairment, and Alzheimer's disease: A cross-sectional study" [Exp. Gerontol. 131 (2020) 110816].
    Exp Gerontol. 2020 Apr 8:110943. doi: 10.1016/j.exger.2020.110943.
    >> Share

  42. ELSWORTHY RJ, Aldred S
    The effect of age and obesity on platelet amyloid precursor protein processing and plasma markers of oxidative stress and inflammation.
    Exp Gerontol. 2020;132:110838.
    >> Share

    March 2020
  43. MOREL E, Armand S, Assal F, Allali G, et al
    Parkinsonian gait in aging: A feature of Alzheimer's pathology?
    Exp Gerontol. 2020 Mar 2:110905. doi: 10.1016/j.exger.2020.110905.
    >> Share

    February 2020
  44. SINGULANI MP, Pereira CPM, Ferreira AFF, Garcia PC, et al
    Impairment of PGC-1alpha-mediated mitochondrial biogenesis precedes mitochondrial dysfunction and Alzheimer's pathology in the 3xTg mouse model of Alzheimer's disease.
    Exp Gerontol. 2020 Feb 18:110882. doi: 10.1016/j.exger.2020.110882.
    >> Share

  45. YAN T, Nian T, Wu B, Xiao F, et al
    Okra polysaccharides can reverse the metabolic disorder induced by high-fat diet and cognitive function injury in Abeta1-42 mice.
    Exp Gerontol. 2020;130:110802.
    >> Share

  46. LIN X, Chen Y, Zhang P, Chen G, et al
    The potential mechanism of postoperative cognitive dysfunction in older people.
    Exp Gerontol. 2020;130:110791.
    >> Share

    December 2019
  47. ZHAO J, Liu P, Hua L, Yang X, et al
    Haplotype analysis on association between variants of interleukin 6 (IL-6) and late-onset Alzheimer's disease in a Chinese Han population.
    Exp Gerontol. 2019 Dec 21:110813. doi: 10.1016/j.exger.2019.110813.
    >> Share

  48. DE OLIVEIRA SILVA F, Ferreira JV, Placido J, Chagas D, et al
    Gait analysis with videogrammetry can differentiate healthy elderly, mild cognitive impairment, and Alzheimer's disease: A cross-sectional study.
    Exp Gerontol. 2019 Dec 17:110816. doi: 10.1016/j.exger.2019.110816.
    >> Share

  49. CAO F, Liu Z, Sun G
    Diagnostic value of miR-193a-3p in Alzheimer's disease and miR-193a-3p attenuates amyloid-beta induced neurotoxicity by targeting PTEN.
    Exp Gerontol. 2019;130:110814.
    >> Share

    October 2019
  50. ARIANNA V, Sonila A, Sofia P, Alessia G, et al
    Erythrocyte membrane fluidity in mild cognitive impairment and Alzheimer's disease patients.
    Exp Gerontol. 2019 Oct 21:110754. doi: 10.1016/j.exger.2019.110754.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016